Orthofix Medical (OFIX) Restructuring Costs (2023 - 2024)
Orthofix Medical's (OFIX) quarterly Restructuring Costs came in at $1.3 million in Q4 2024, up 30.72% YoY from $1.0 million in Q1 2024, and up 160.4% on a QoQ basis from $505000.0 in Q3 2024.
Orthofix Medical (OFIX) Restructuring Costs (2023 - 2024) Analysis & Trends
Orthofix Medical (OFIX) has 2 years of Restructuring Costs data on file, last reported at $1.3 million in Q4 2024.
- Quarterly Restructuring Costs rose 30.72% year-over-year to $1.3 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $9.4 million (down 51.61% YoY) and the FY2024 annual result came in at $9.4 million, up 697.28% from the prior year.
- Restructuring Costs grew to $1.3 million in Q4 2024, from $505000.0 in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $18.2 million in Q1 2023 to a low of -$92000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn |
| 10 | Orthofix Medical | 414.38 Mn | 309.97 Mn | 149.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.32 Mn |
| Sep 30, 2024 | 505,000.00 |
| Jun 30, 2024 | 5.35 Mn |
| Mar 31, 2024 | 2.21 Mn |
| Dec 31, 2023 | 1.01 Mn |
| Sep 30, 2023 | -92,000.00 |
| Jun 30, 2023 | 262,000.00 |
| Mar 31, 2023 | 18.20 Mn |